0001387131-22-007495.txt : 20220707
0001387131-22-007495.hdr.sgml : 20220707
20220707162454
ACCESSION NUMBER: 0001387131-22-007495
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220707
DATE AS OF CHANGE: 20220707
EFFECTIVENESS DATE: 20220707
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp
CENTRAL INDEX KEY: 0000887247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820429727
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-451511
FILM NUMBER: 221071907
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 997-2400
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950615
D
1
primary_doc.xml
X0708
D
LIVE
0000887247
Adamis Pharmaceuticals Corp
11682 EL CAMINO REAL
SUITE 300
SAN DIEGO
CA
CALIFORNIA
92130
858-997-2400
DELAWARE
CELLEGY PHARMACEUTICALS, INC.
CELLEGY PHARMACEUTICALS INC
Corporation
true
Richard
C.
Williams
11682 EL CAMINO REAL
SUITE 300
San Diego
CA
CALIFORNIA
92130
Director
Howard
C.
Birndorf
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Director
Meera
J.
Desai
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Director
David
J.
Marguglio
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Vickie
S.
Reed
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Director
David
C.
Benedicto
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Executive Officer
Ronald
B.
Moss
11682 EL CAMINO REAL
Suite 300
San Diego
CA
CALIFORNIA
92130
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-07-05
false
true
true
true
false
0
300000
300000
0
false
1
0
0
0
false
Adamis Pharmaceuticals Corp
/s/ David J. Marguglio
David J. Marguglio
President, Chief Executive Officer
2022-07-06